| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
Denis Angioletti
BRD | Director/Board Member | 58 | 2019-12-31 |
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +1.37% | +3.51% | +43.52% | +151.14% | 996B | |
| +1.62% | +7.64% | +61.43% | +50.24% | 580B | |
| +3.02% | +12.12% | +30.93% | +79.87% | 415B | |
| +5.66% | -2.44% | +22.01% | +15.66% | 326B | |
| +1.34% | +6.74% | +32.63% | +41.70% | 280B | |
| +1.09% | +6.90% | +37.22% | +24.53% | 284B | |
| +1.32% | +12.69% | -27.48% | -41.27% | 210B | |
| +1.27% | +5.47% | +27.01% | +58.44% | 190B | |
| -0.37% | +0.99% | +17.99% | +63.26% | 155B | |
| Average | +1.64% | +2.68% | +27.25% | +49.28% | 381.86B | |
| Weighted average by Cap. | +1.95% | +2.18% | +35.18% | +72.42% |
Employees
4
Sector
Pharmaceuticals
